Back to Top
Contribution
SUSTech_Shenzhen 2019 iGEM team have contributed the characterization of part BBa_K1537016 by linked the 2A sequence with two target protein (cytokine IL-10 and eGFP, enhanced green fluorescent protein) and measured the expression level of the desired protein. By the measurement data, we conformed the feasibility of 2A peptide in a new chassis (HeLa cell). We also provided quantitative data to analyze the influence of 2A's cleavage function on the expression level of downstream protein.
First, we obtained the DNA sequence of 2A peptide from 2019 iGEM distribution and linked our target protein sequence to construct two plasmid: 5xUAS-EGFP and 5xUAS-IL10-2A-EGFP, 5xUAS is the binding site of part BBa_K2986003(GAVPO, a light-switchable trans activator). (figure1-2: plasmid construction)
From figure 3-6, we conformed that this part is functional in HeLa cell line: the IL-10 and eGFP is cleaved by 2A peptide and successfully expressed. Our quantitative data from figure 3-4 also provided another characterization feature of 2A peptide: expression level of the latter protein linked after 2A (eGFP level in the IL10-2A-eGFP cell line) is lower than the control group without 2A (eGFP cell line). The eGFP expression level after 2A is decreased 29.64%.